Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains

[1]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.

[2]  H. Fibiger,et al.  Direct evidence for presynaptic and postsynaptic dopamine receptors in brain , 1978, Nature.

[3]  P. Seeman,et al.  Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. , 1977, Life sciences.

[4]  L. Iversen,et al.  INCREASED BRAIN DOPAMINE AND REDUCED GLUTAMIC ACID DECARBOXYLASE AND CHOLINE ACETYL TRANSFERASE ACTIVITY IN SCHIZOPHRENIA AND RELATED PSYCHOSES , 1977, The Lancet.

[5]  P. Seeman,et al.  Anti-schizophrenic drugs--membrane receptor sites of action. , 1977, Biochemical pharmacology.

[6]  J. Leysen,et al.  Specific in vivo binding of neuroleptic drugs in rat brain. , 1977, Biochemical pharmacology.

[7]  S. Snyder,et al.  Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.

[8]  P. Seeman,et al.  Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Seeman,et al.  Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.

[10]  D. Janowsky,et al.  Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. , 1976, Archives of general psychiatry.

[11]  O Kennard,et al.  Dopamine receptor blockade and the neuroleptics, a crystallographic study , 1975, The Journal of pharmacy and pharmacology.

[12]  R. Baldessarini,et al.  Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. , 1974, Neuropharmacology.

[13]  S. Merlis,et al.  The action of L-dopa on schizophrenic patients (a preliminary report). , 1970, Current therapeutic research, clinical and experimental.

[14]  J. Delay,et al.  [Therapeutic method derived from hiberno-therapy in excitation and agitation states]. , 1952, Annales medico-psychologiques.

[15]  O. Hornykiewicz.  Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence. , 1977, Annual review of pharmacology and toxicology.

[16]  S. Snyder,et al.  The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. , 1976, The American journal of psychiatry.

[17]  S. Matthysse,et al.  Biochemical aspects of schizophrenia. , 1975, Annual review of medicine.

[18]  P. Seeman,et al.  Membrane stabilization by drugs: tranquilizers, steroids, and anesthetics. , 1966, International review of neurobiology.